NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that on October 6, 2009 the Board of Directors of Synergy Pharmaceuticals, Inc. appointed Alan F. Joslyn, Ph.D. as a director of the Company. In addition, the Board of Directors appointed Dr. Joslyn as Chairman of the Corporate Governance/Nominating Committee.
